| 000 | 01357 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512195607.0 | ||
| 264 | 0 | _c19820621 | |
| 008 | 198206s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(82)92149-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlint, E J | |
| 245 | 0 | 0 |
_aEffect of GL enzyme (a highly purified form of hyaluronidase) on mortality after myocardial infarction. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cApr 1982 |
||
| 300 |
_a871-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyaluronoglucosaminidase _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aDe Giovanni, J | |
| 700 | 1 | _aCadigan, P J | |
| 700 | 1 | _aLamb, P | |
| 700 | 1 | _aPentecost, B L | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8277 _gp. 871-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(82)92149-3 _zAvailable from publisher's website |
| 999 |
_c6122187 _d6122187 |
||